Vericel Corporation shares fall 3.52% intraday after former CFO Gerard Michel appointed to Beta Bionics board.

Vericel Corporation declined 3.52% in intraday trading. The drop in stock price may be attributed to the recent news of Gerard Michel, the former Chief Financial Officer of Vericel Corporation, being appointed as an independent member of the board of directors for Beta Bionics, Inc. This news could be perceived as bearish for Vericel Corporation, as it may indicate a shift in focus or resources for Mr. Michel, who has over 30 years of experience in the pharmaceutical and medical technology industries.